Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on February 19, 2009

Stroke. 2009
Published online before print February 19, 2009, doi: 10.1161/STROKEAHA.108.534644
A more recent version of this article appeared on April 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/4/1467    most recent
STROKEAHA.108.534644v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narasimhan, P.
Right arrow Articles by Chan, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narasimhan, P.
Right arrow Articles by Chan, P. H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
*OXYGEN
Medline Plus Health Information
*Transient Ischemic Attack
Related Collections
Right arrow Apoptosis
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Ischemic biology - basic studies
Right arrow Endothelium/vascular type/nitric oxide

Submitted on August 13, 2008
Revised on October 21, 2008
Accepted on October 24, 2008

VEGF Stimulates the ERK 1/2 Signaling Pathway and Apoptosis in Cerebral Endothelial Cells After Ischemic Conditions

Purnima Narasimhan PhD; Jing Liu MD, PhD; Yun Seon Song PhD; Justin L. Massengale MD; and Pak H. Chan PhD*

From the Department of Neurosurgery, Department of Neurology and Neurological Sciences, and Program in Neurosciences, Stanford University School of Medicine, Stanford, Calif.

* To whom correspondence should be addressed. E-mail: phchan{at}stanford.edu.

Background and Purpose—Cerebral endothelial cells that line microvessels play an important role in maintaining blood flow homeostasis within the brain-forming part of the blood–brain barrier. These cells are injured by hypoxia-induced reperfusion, leading to blood–brain barrier breakdown and exacerbation of ischemic injury. We investigated the roles of vascular endothelial growth factor (VEGF) and the downstream extracellular signal-regulated kinase (ERK) protein after oxygen-glucose deprivation (OGD) in primary endothelial cells.

Methods—Primary mouse endothelial cells were isolated and subjected to OGD. Western analysis of VEGF and ERK 1/2 protein levels was performed. Cells were transfected with VEGF small interference RNA. A terminal deoxynucleotidyl transferase-mediated uridine 5'-triphosphate-biotin nick end labeling (TUNEL) assay and DNA fragmentation assay were used on mouse endothelial cells that overexpress copper/zinc-superoxide dismutase (SOD1).

Results—VEGF protein expression was induced and its receptor, Flk-1, was stimulated by OGD. Phosphorylation of ERK 1/2 protein levels was upregulated. Inhibition of phosphorylated ERK (pERK) expression by U0126 reduced endothelial cell death by OGD. Transfection of small interfering RNA for VEGF also inhibited an increase in pERK, suggesting that VEGF acts via ERK. The TUNEL and DNA fragmentation assays showed a significant decrease in TUNEL-positivity in the SOD1-overexpressing endothelial cells compared with wild-type cells after OGD.

Conclusions—Our data suggest that OGD induces VEGF signaling via its receptor, Flk-1, and activates ERK via oxidative-stress-dependent mechanisms. Our study shows that in cerebral endothelial cells the ERK 1/2 signaling pathway plays a significant role in cell injury after OGD.


Key words: endothelial cells • oxidative stress • superoxide dismutase • VEGF